NASSAU HENRY N
Known title: DirectorCIK: 0001177127
NASSAU HENRY N's purchase track record
How the stock did after each of NASSAU HENRY N's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 5 since November 2, 2021
Stock higher 6 months later
75%
3 months: 75%
Median 6-month return
+8.9%
3 months: +7.1%
Beat the S&P 500
50%
median +3.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/4/2026 | BXMT | $143K | pending | pending | — |
| 5/6/2025 | BXMT | $189K | +3.5% | +4.4% | +20.8% |
| 8/8/2024 | BXMT | $175K | +10.7% | +13.4% | +14.4% |
| 3/15/2023 | BXMT | $178K | +15.1% | +34.9% | +14.8% |
| 11/2/2021 | BXMT | $982K | -2.3% | -1.7% | -9.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BXMT | ▲ Buy | Open Market | 10,000 | $143K | 8/4/2026 | View on chart |
| BXMT | ▲ Buy | Grant | 3,044 | $52K | 7/15/2026 | View on chart |
| BXMT | ▲ Buy | Grant | 6,597 | $115K | 6/26/2026 | View on chart |
| BXMT | ▲ Buy | Grant | 2,531 | $51K | 4/15/2026 | View on chart |
| BXMT | ▲ Buy | Grant | 2,550 | $50K | 1/15/2026 | View on chart |
| BXMT | ▲ Buy | Grant | 2,620 | $48K | 10/15/2025 | View on chart |
| BXMT | ▲ Buy | Grant | 2,407 | $47K | 7/15/2025 | View on chart |
| BXMT | ▲ Buy | Grant | 5,828 | $115K | 6/27/2025 | View on chart |
| BXMT | ▲ Buy | Open Market | 10,000 | $189K | 5/6/2025 | View on chart |
| BXMT | ▲ Buy | Grant | 2,517 | $46K | 4/15/2025 | View on chart |
| BXMT | ▲ Buy | Grant | 2,479 | $45K | 1/15/2025 | View on chart |
| BXMT | ▲ Buy | Grant | 2,393 | $44K | 10/15/2024 | View on chart |
| BXMT | ▲ Buy | Open Market | 10,000 | $175K | 8/8/2024 | View on chart |
| BXMT | ▲ Buy | Grant | 2,950 | $56K | 7/15/2024 | View on chart |
| BXMT | ▲ Buy | Grant | 6,378 | $115K | 6/21/2024 | View on chart |
| BXMT | ▲ Buy | Grant | 2,969 | $54K | 4/15/2024 | View on chart |
| BXMT | ▲ Buy | Grant | 2,531 | $53K | 1/16/2024 | View on chart |
| BXMT | ▲ Buy | Grant | 2,418 | $51K | 10/13/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 2,252 | $50K | 7/17/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 5,927 | $115K | 6/23/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 2,784 | $48K | 4/14/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 2,784 | $48K | 4/14/2023 | View on chart |
| BXMT | ▲ Buy | Open Market | 10,000 | $178K | 3/15/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 2,005 | $47K | 1/13/2023 | View on chart |
| BXMT | ▲ Buy | Grant | 2,040 | $46K | 10/14/2022 | View on chart |
| BXMT | ▲ Buy | Grant | 1,560 | $45K | 7/15/2022 | View on chart |
| BXMT | ▲ Buy | Grant | 4,399 | $115K | 6/16/2022 | View on chart |
| BXMT | ▲ Buy | Grant | 1,369 | $44K | 4/14/2022 | View on chart |
| BXMT | ▲ Buy | Grant | 1,344 | $43K | 1/14/2022 | View on chart |
| BXMT | ▲ Buy | Open Market | 30,000 | $982K | 11/2/2021 | View on chart |
| BXMT | ▲ Buy | Grant | 1,308 | $42K | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Blackstone Mortgage Trust (BXMT) Faces Analyst Target Cut Amid REIT Bounce
Recent commentary notes that REITs have halted recent declines, bringing attention back to Blackstone Mortgage Trust. Analysts argue the stock may already reflect earnings expectations, while Keefe, Bruyette & Woods kept a market‑perform rating but lowered its price target to $13. The firm’s high dividend yield and a low RSI suggest it is oversold, with support around $17.57. These factors combine to keep the stock in focus.
Blackstone Mortgage Trust (BXMT) Faces Analyst Target Cut Amid REIT Bounce. Recent commentary notes that REITs have halted recent declines, bringing attention back to Blackstone Mortgage Trust. Analysts argue the stock may already reflect earnings expectations, while Keefe, Bruyette & Woods kept a market‑perform rating but lowered its price target to $13. The firm’s high dividend yield and a low RSI suggest it is oversold, with support around $17.57. These factors combine to keep the stock in focus.